Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/7271
Title: | Loss of CEACAM1 in hepatocytes causes hepatic fibrosis | Authors: | Zaidi, Sobia Asalla, Suman Muturi, Harrison T Russo, Lucia Abdolahipour, Raziyeh Belew, Getachew Debas Iglesias, Maria Benitez Feraudo, Mary Leon, Lensay Kuo, Enoch Liu, Xiuli Kumarasamy, Sivarajan Ghadieh, Hilda Gatto-Weis, Cara Zarrinpar, Ali Duarte, Sergio Najjar, Sonia M |
Affiliations: | Faculty of Medicine | Keywords: | Fibrosis stage Hepatic stellate cells Insulin extraction Insulin resistance Steatohepatitis |
Issue Date: | 2024-02-21 | Part of: | European Journal of Clinical Investigation | Abstract: | The role of insulin resistance in hepatic fibrosis in Metabolic dysfunction-Associated SteatoHepatitis (MASH) remains unclear. Carcinoembryonic Antigen-related Cell Adhesion Molecule1 protein (CEACAM1) promotes insulin clearance to maintain insulin sensitivity and repress de novo lipogenesis, as bolstered by the development of insulin resistance and steatohepatitis in AlbuminCre + Cc1fl/fl mice with liver-specific mouse gene encoding CEACAM1 protein (Ceacam1) deletion. We herein investigated whether these mice also developed hepatic fibrosis and whether hepatic CEACAM1 is reduced in patients with MASH at different fibrosis stages. |
URI: | https://scholarhub.balamand.edu.lb/handle/uob/7271 | ISSN: | 00142972 | DOI: | 10.1111/eci.14177 | Type: | Journal Article |
Appears in Collections: | Faculty of Medicine |
Show full item record
SCOPUSTM
Citations
8
checked on Dec 21, 2024
Record view(s)
46
checked on Dec 26, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.